This Week In Fitness: Eli Lilly's Retatrutide Results, Crunch Expands & ClassPass Updates

This week on This Week In Fitness, we're covering one of the biggest obesity drug developments of the year as Eli Lilly reports positive Phase 3 results for retatrutide, a potential next-generation obesity treatment. We also look at ClassPass' new partner protections for gyms and studios, Crunch Fitness' $100 million expansion into Phoenix, Ultimate Longevity Center's rapid franchise growth, Planet Fitness' new partnership with Apple Music, and Wattbike's integration with EGYM. Stories this w...